Gainers
Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private investment positions.
Sotera Health Company ("The Company") (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today
Reaffirming 2023 Outlook
Today, Sotera Health is reaffirming the 2023 outlook first provided on February 28, 2023. That outlook is:
Net revenues in the range of $1.055 to $1.090 billion, representing growth of